Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis

PloS One
Hiromitsu ItoMinoru Tanabe

Abstract

Patients with pancreatic cancer typically develop tumor invasion and metastasis in the early stage. These malignant behaviors might be originated from cancer stem cells (CSCs), but the responsible target is less known about invisible CSCs especially for invasion and metastasis. We previously examined the proteasome activity of CSCs and constructed a real-time visualization system for human pancreatic CSCs. In the present study, we found that CSCs were highly metastatic and dominantly localized at the invading tumor margins in a liver metastasis model. Microarray and siRNA screening assays showed that doublecortin-like kinase 1 (DCLK1) was predominantly expressed with histone modification in pancreatic CSCs with invasive and metastatic potential. Overexpression of DCLK1 led to amoeboid morphology, which promotes the migration of pancreatic cancer cells. Knockdown of DCLK1 profoundly suppressed in vivo liver metastasis of pancreatic CSCs. Clinically, DCLK1 was overexpressed in the metastatic tumors in patients with pancreatic cancer. Our studies revealed that DCLK1 is essential for the invasive and metastatic properties of CSCs and may be a promising epigenetic and therapeutic target in human pancreatic cancer.

References

Jun 5, 2001·Nature Reviews. Neuroscience·Y Feng, C A Walsh
Nov 2, 2001·Nature·T ReyaI L Weissman
May 2, 2003·Nature Reviews. Cancer·Peter Friedl, Katarina Wolf
May 10, 2005·International Journal of Cancer. Journal International Du Cancer·Mitsuhiko MurakamiMasao Tanaka
Feb 9, 2006·The Journal of Biological Chemistry·Marios GiannakisJeffrey I Gordon
Nov 24, 2006·Nature·Lucia Ricci-VitianiRuggero De Maria
Feb 7, 2007·Cancer Research·Chenwei LiDiane M Simeone
Jun 10, 2008·Nature Protocols·Andrew Chojnacki, Samuel Weiss
Sep 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Diane M Simeone
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Feb 27, 2009·Journal of the National Cancer Institute·Erina VlashiFrank Pajonk
Aug 19, 2009·Nature Reviews. Clinical Oncology·Gregory SergeantBaki Topal
Mar 26, 2011·Science·Christine L Chaffer, Robert A Weinberg
Aug 8, 2012·The Journal of Cell Biology·Irène Baccelli, Andreas Trumpp
Sep 4, 2012·Mutation Research·Nina KramerHelmut Dolznig
Oct 30, 2012·Nature·Andrew V BiankinSean M Grimmond
Dec 4, 2012·Nature Genetics·Yuki NakanishiTsutomu Chiba
Mar 1, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shunsuke MuramatsuShigeki Arii
Dec 3, 2013·Nature Medicine·Antonija KresoCatherine A O'Brien
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 4, 2014·The Journal of Clinical Investigation·C Benedikt WestphalenTimothy C Wang
Feb 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Irene IschenkoMichael J Hayman
Mar 13, 2014·Cell Stem Cell·Thordur OskarssonJoan Massagué
Jun 1, 2014·Cancer Letters·Sripathi M SurebanCourtney W Houchen
Sep 11, 2014·The New England Journal of Medicine·David P RyanNabeel Bardeesy

❮ Previous
Next ❯

Citations

Jul 30, 2016·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Lorenz KadletzClaudia Lill
Jul 28, 2016·Small GTPases·C Benedikt WestphalenTimothy C Wang
Oct 6, 2017·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Amrita RamkumarKassandra M Ori-McKenney
Mar 1, 2017·Journal of Cellular and Molecular Medicine·Hengqiang ZhaoTao Yin
Sep 6, 2019·Molecular Biology Reports·Arkadiusz GzilŁukasz Szylberg
Nov 2, 2016·Cancer Biomarkers : Section a of Disease Markers·Alireza MirzaeiGholamreza Tavoosidana
Aug 2, 2017·International Journal of Molecular Sciences·Jee-Heun KimJeong-Seok Nam
Jun 21, 2018·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Yuzo HaradaToshiaki Watanabe
Feb 10, 2017·Molecular Cancer Research : MCR·Yu IkezonoTakuji Torimura
Sep 27, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nevi LorenzoAlvaro Domenico
Mar 4, 2021·Critical Reviews in Food Science and Nutrition·Laleh Arzi, Reyhane Hoshyar
May 6, 2021·International Journal of Molecular Sciences·Susmita BarmanPunita Dhawan
Jul 17, 2021·Pathology, Research and Practice·Kuangjing WangZhining Fan
Aug 29, 2021·Cancer Metastasis Reviews·Kalyani PatilShahab Uddin
Aug 7, 2020·Cell Chemical Biology·Yan LiuKenneth D Westover
Dec 24, 2021·Expert Review of Gastroenterology & Hepatology·Yifan WangXiaowei Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence
flow cytometry
transfection
immunoprecipitation
ChIP
surgical resection
Flow

Software Mentioned

AxioVision
Expression [UNK]
Affymetrix

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.